What technical indicators reveal about VFC stock

While VF Corp has underperformed by -4.21%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, VFC fell by -43.85%, with highs and lows ranging from $29.02 to $9.41, whereas the simple moving average fell by -30.98% in the last 200 days.

On July 31, 2025, BNP Paribas Exane Downgraded VF Corp (NYSE: VFC) to Underperform. A report published by Telsey Advisory Group on May 14, 2025, Reiterated its previous ‘Market Perform’ rating for VFC. Wells Fargo also Upgraded VFC shares as ‘Equal Weight’, setting a target price of $12 on the company’s shares in a report dated April 30, 2025. Needham initiated its ‘Buy’ rating for VFC, as published in its report on February 12, 2025. Truist also rated the stock as ‘Hold’.

Analysis of VF Corp (VFC)

VFC currently pays a dividend of $0.36 per share, which means investors will get a return regardless of the company’s performance over the next few months. Further, the quarter-over-quarter decrease in sales is -7.79%, showing a negative trend in the upcoming months.

In order to gain a clear picture of VF Corp’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 7.83% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.65, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

An average volume of 8.70M can be a very valuable indicator of volatility for VFC stock. On a monthly basis, the volatility of the stock is set at 5.26%, whereas on a weekly basis, it is put at 9.70%, with a loss of -2.82% over the past seven days. Furthermore, long-term investors anticipate a median target price of $13.50, showing growth from the present price of $12.05, which can serve as yet another indication of whether VFC is worth investing in or should be passed over.

How Do You Analyze VF Corp Shares?

The USA based company VF Corp (VFC) is one of the biggest names in Apparel Manufacturing. When comparing VF Corp shares with other companies under Consumer Cyclical, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 55.48, there is a growth in quarterly earnings of 55.18%.

In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 6.32%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 96.19% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

VFC shares are owned by institutional investors to the tune of 96.19% at present.

Hot this week

Procept BioRobotics Corp (PRCT)’s stock chart: A technical perspective

While Procept BioRobotics Corp has underperformed by -1.13%, investors...

Chewy Inc (CHWY)’s stock performance: a year in review

While Chewy Inc has overperformed by 2.45%, investors are...

Arcus Biosciences Inc (RCUS)’s stock price in review: A technical analysis

While Arcus Biosciences Inc has overperformed by 0.47%, investors...

A closer look at Edgewell Personal Care Co (EPC)’s stock price trends

While Edgewell Personal Care Co has overperformed by 0.51%,...

Arrowhead Pharmaceuticals Inc (ARWR)’s stock rises to 22.34 per share

While Arrowhead Pharmaceuticals Inc has overperformed by 2.52%, investors...

Topics

Procept BioRobotics Corp (PRCT)’s stock chart: A technical perspective

While Procept BioRobotics Corp has underperformed by -1.13%, investors...

Chewy Inc (CHWY)’s stock performance: a year in review

While Chewy Inc has overperformed by 2.45%, investors are...

Arcus Biosciences Inc (RCUS)’s stock price in review: A technical analysis

While Arcus Biosciences Inc has overperformed by 0.47%, investors...

A closer look at Edgewell Personal Care Co (EPC)’s stock price trends

While Edgewell Personal Care Co has overperformed by 0.51%,...

Arrowhead Pharmaceuticals Inc (ARWR)’s stock rises to 22.34 per share

While Arrowhead Pharmaceuticals Inc has overperformed by 2.52%, investors...

Yext Inc (YEXT) stock analysis: A comprehensive overview

While Yext Inc has overperformed by 0.22%, investors are...

Zevra Therapeutics Inc (ZVRA)’s stock price range in the last year

While Zevra Therapeutics Inc has underperformed by -0.64%, investors...

Kontoor Brands Inc (KTB) stock: A year of ups and downs

While Kontoor Brands Inc has underperformed by -1.58%, investors...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.